AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).
The current price of AbbVie Inc in the market is 9 148,47 ₴, with a 24-hour trading volume of 42,71B ₴. The asset's market cap is 16,18T ₴, after moving 1.84% in the last day.
Tokenized AbbVie Inc is trading at 9 203,62 ₴, with a tokenized market cap of 631,35M ₴ and a 24-hour trading volume of 40,01M ₴. The tokenized asset has moved 2.65% in the past 24 hours.